Other studies have demonstrated an over-expression of TWIST in BM mononuclear cells of patients with AML [210,211], and this correlated with a more aggressive clinical phenotype [210], and shorter overall and event-free survival in multivariate analysis [211], thus identifying TWIST as a novel candidate gene contributing to leukemogenesis. Here, TWIST1 is linked to acute myeloid leukemia.